Historical record - last NADAC effective date: 8/21/2024
Product Information
FELBAMATE 600 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.6020 per ML under NDC 65162068690. Its NADAC has been published 109 times since Dec 18, 2013.
FDA first approved this application on Dec 16, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/5mL
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162068690
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/21/2024
Active Ingredients
FELBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA202385FDA Approved
12/16/2011
TE Code
AB
On Market Since
12/16/2011
Pharmacological Classes
Price Statistics
The NADAC for FELBAMATE 600 MG/5 ML SUSP has been published 109 times since Dec 18, 2013, and over the history we have for it it has declined 69.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6020 per ML |
|---|---|
| All-time high | $1.9509 (Jan 14, 2015) |
| All-time low | $0.6020 (Aug 21, 2024) |
| Median price | $1.9509 |
| Average price | $1.3074 |
| Largest weekly change | -69.1% (Aug 21, 2024) |
| Weeks tracked | 109 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-69.1%
5Y
-69.1%
All
-69.1%
Last surveyed Aug 13, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Felbamate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FELBAMATE 600 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 600 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals LLC, is $0.6020 per ML (NDC 65162068690), effective Aug 13, 2025.
How has the price of FELBAMATE 600 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for FELBAMATE 600 MG/5 ML SUSP has declined 69.1%. It has been tracked across 109 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for FELBAMATE 600 MG/5 ML SUSP?
Since Dec 18, 2013, the NADAC for FELBAMATE 600 MG/5 ML SUSP has ranged from a low of $0.6020 (Aug 21, 2024) to a high of $1.9509 (Jan 14, 2015), with a median of $1.9509 per ML.
Are there cheaper alternatives to FELBAMATE 600 MG/5 ML SUSP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FELBAMATE 600 MG/5 ML SUSP, is $0.3561 per ML — about 41% below FELBAMATE 600 MG/5 ML SUSP.
Who manufactures FELBAMATE 600 MG/5 ML SUSP?
FELBAMATE 600 MG/5 ML SUSP (NDC 65162068690) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.